Frisina N, Buemi M, Lasco A, Macrí I, Ciraolo O, Nicita Mauro V, Costa G
Boll Soc Ital Biol Sper. 1980 Jul 15;56(13):1367-73.
The Authors have studied, in a group of hypertensive subjects with low renin, the behavior of arterial blood pressure, PRA, plasma aldosterone, plasma K and Na, after intravenous load of Saralasin before and after treatment with Furosmide (40 mg orally given for 4 days). In such conditions we evidenced an agonist effect of Saralasin mainly on plasma aldosterone and less on arterial pressure. The Authors conclude that Saralasin, in given conditions (free receptor sites), can exhibit on agonist effect on aldosterone secretion; such agonist effect can be augmented by dopaminergic deficit, that sometimes in present is essential arterial hypertension.
作者们对一组低肾素型高血压患者进行了研究,观察在静脉注射沙拉新前后以及用速尿(口服40毫克,共4天)治疗后,动脉血压、血浆肾素活性(PRA)、血浆醛固酮、血浆钾和钠的变化情况。在这些情况下,我们证实沙拉新主要对血浆醛固酮有激动剂作用,而对动脉血压的作用较小。作者们得出结论,在特定条件下(存在游离受体位点),沙拉新可对醛固酮分泌产生激动剂作用;这种激动剂作用可因多巴胺能缺乏而增强,而多巴胺能缺乏有时在原发性高血压中是存在的。